Zobacz wszystkie

Biotie Therapies Oyj: Correction to Stock Exchange Release: Change in the number of votes relating to Biotie Therapies Corp.'s shares published 30 July at 8.45 am

2014-08-01 09:41:00
Ticker Giełda ISIC Kraj Miasto
BTH1V XHEL Finland Turku

BIOTIE THERAPIES CORP.                  Stock Exchange Release            1

August 2014 at 10.40 am

Correction to Stock Exchange Release: Change in the number of votes relating to

Biotie Therapies Corp.'s shares published 30 July at 8.45 am

Biotie corrects its release published on July 30 regarding change in the number

of votes. Corrections relate to the following items: Increase in number of

outstanding shares, total amount of voting rights and number of the Company's

shares held by the Group. Below is the corrected release in its entirety:

Biotie Therapies Corp. ("Biotie" or the "Company") has conveyed Biotie shares

held as treasury shares, that were issued on 2 January 2014, pursuant to the

Stock Option Plan 2011 and the Equity Incentive Plan 2011 (the "Plans") as


Shares Cumulative shares Remaining shares to

conveyed conveyed since 2 January 2014  be conveyed

1,812,910 3,059,160 262,500

Under the Stock Option Plan 2011, the owners of the stock options may subscribe

for a maximum total of 7,401,000 new shares in the Company or existing shares

held by the Company. A total of 766,750 shares have been subscribed for during

the period 9 May 2014 and 29 July 2014 and 766,750 of the treasury shares will

be used for these share subscriptions. The subscription price of EUR 0.01 per

share has been fully paid by the employee and the EUR 7,667.50 funds received

will be credited to the Company's reserve for non-restricted equity.

The first vesting period of the Equity Incentive Plan 2011 ended on 5 January

2014, after which the Company's shares shall be delivered to employees on the

basis of the granted share units. It was resolved pursuant to the authorization

of the Annual General Meeting of the Shareholders held on 4 April 2013 to issue

1,046,160 existing treasury shares to the employees without consideration for

the purposes of remunerating the employees pursuant to the terms and conditions

of the Equity Incentive Plan 2011 and thus, there is an especially weighty

financial reason to derogate from the pre-emptive right of the shareholders, as

referred to in Chapter 9 Section 4(1) of the Companies Act (624/2006, as


The conveyed shares previously held as treasury shares have not carried any

voting rights. The conveyance does not affect the number of registered shares.

After the conveyances the changes are as follows:

Increase in number Total amount of Number of the Total number

 of outstanding shares voting rights Company's share held of registered

by the Group shares

1,812,910 449,515,822 6,516,576 456,032,398

Turku, 1 August 2014

Biotie Therapies Corp.

Timo Veromaa, President and CEO

For further information, please contact:

Virve Nurmi, Investor Relations Manager, Biotie Therapies Corp.

tel. +358 2 274 8900, e-mail: virve.nurmi@biotie.com



NASDAQ OMX Helsinki Ltd

Main Media

This announcement is distributed by GlobeNewswire on behalf of

GlobeNewswire clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and

other applicable laws; and

(ii) they are solely responsible for the content, accuracy and

originality of the information contained therein.

Source: Biotie Therapies Oyj via GlobeNewswire